- Deset let zkušeností s léčbou relapsu akutní lymfoblastické leukémie v dětském věku1997 | 2. lékařská fakulta
- Relapsed acute lymphoblastic leukemia-specific mutations in NT5C2 cluster into hotspots driving intersubunit stimulation2018 | 2. lékařská fakulta
- Other (Non-cns/testicular) extramedullary localizations of childhood relapsed acute lymphoblastic leukemia and lymphoblastic lymphoma-a report from the all-rez study group2021 | 2. lékařská fakulta
- CD38: A target in relapsed/refractory acute lymphoblastic leukemia-Limitations in treatment and diagnostics2022 | 2. lékařská fakulta
- Use of Allogeneic Hematopoietic Stem-Cell Transplantation Based on Minimal Residual Disease Response Improves Outcomes for Children With Relapsed Acute Lymphoblastic Leukemia in the Intermediate-Risk Group2013 | 2. lékařská fakulta
- Childhood secondary ALL after ALL treatment2007 | 2. lékařská fakulta, Ústřední knihovna
- Minimal residual disease analysis by eight-color flow cytometry in relapsed childhood acute lymphoblastic leukemia2015 | 2. lékařská fakulta
- Monitoring minimal residual disease in children with high-risk relapses of acute lymphoblastic leukemia: prognostic relevance of early and late assessment2015 | 2. lékařská fakulta
- Výskyt a léčba relapsu dětské akutní lymfoblastické leukémie v České republice v letech 1990-20002003 | 2. lékařská fakulta
- Low rate of nonrelapse mortality in under 4-year-olds with ALL given chemo-conditioning for HSCT: Phase III FORUM study2024 | 2. lékařská fakulta